In-Ho Chae

Showing 1-3 of 3 articles

Coronary interventions

Clinical outcomes of long stent in the drug-eluting stent era: patient-level pooled analysis from the GRAND-DES registry

Kong MG, Han J-K, Kang J, Zheng C, Yang H, Park K, Kang H-J, Boo B, Chae I, Kim H, Choi YJ, Shin E, Bae J-W, Chun K-J, Kim D, Rha S, Lee S, Rhew JY, Woo S-I, Lee HC, Jeong J-O

September 24, 2019 | 10.4244/EIJ-D-19-00296

Stents and scaffolds

Long-term safety of bioresorbable scaffolds: insights from a network meta-analysis including 91 trials

Kang S, Gogas B, Jeon K, Park J-S, Lee W, Yoon C, Suh J-W, Hwang S-S, Youn T, Chae I, Kim H

March 20, 2018 | 10.4244/EIJ-D-17-00646

Coronary interventions

Angiographic outcomes of Orsiro biodegradable polymer sirolimus-eluting stents and Resolute Integrity durable polymer zotarolimus-eluting stents: results of the ORIENT trial

Kang S, Chung W-Y, Lee J, Park J-J, Yoon C, Suh J-W, Cho Y-S, Doh J, Cho J, Bae J-W, Youn T, Chae I

January 20, 2017 | 10.4244/EIJ-D-16-00179

1

Latest news

CTOs, next-day discharge after TAVI, ViV, cerebral embolic protection, TMVR

Ahead of Print: Coronary Artery Thrombosis in COVID-19

Coronary collaterals, the natural grafts of CTO lesions

TWILIGHT, ONYX ONE, DKCRUSH-V and much more

(The Trials book is supported by Biotronik)

August 11, 2020

Guidance Papers

Guidelines, consensus & position papers

Intravascular ultrasound in PCI for in-stent CTO: guidance for long-term success

JM De la Torre Hernandez

This Week's JAA's: Real-world Use of the Evolut PRO Valve...

Valvular disease